| Analog Devices, Third Quarter, Fiscal 2015 | ||||||||||||
|
Schedule C |
||||||||||||
| Cash Flow Statement (Unaudited) | ||||||||||||
| (In thousands) | ||||||||||||
| Three Months Ended | ||||||||||||
| 3Q 15 | 2Q 15 | 3Q 14 | ||||||||||
|
Aug. 1,
2015 |
May 2,
2015 |
Aug. 2,
2014 |
||||||||||
| Cash flows from operating activities: | ||||||||||||
| Net Income | $ | 216,478 | $ | 205,338 | $ | 180,606 | ||||||
|
Adjustments to reconcile net income to net cash provided by operations: |
||||||||||||
| Depreciation | 33,650 | 32,036 | 28,353 | |||||||||
| Amortization of intangibles | 23,898 | 25,154 | 1,610 | |||||||||
| Stock-based compensation expense | 16,364 | 16,101 | 13,470 | |||||||||
| Other non-cash activity | 3,827 | 1,832 | 1,006 | |||||||||
| Excess tax benefit - stock options | (6,373 | ) | (11,142 | ) | (9,322 | ) | ||||||
| Deferred income taxes | (17,168 | ) | (6,481 | ) | (6,380 | ) | ||||||
| Changes in operating assets and liabilities | (73,537 | ) | 81,193 | 4,099 | ||||||||
| Total adjustments | (19,339 | ) | 138,693 | 32,836 | ||||||||
| Net cash provided by operating activities | 197,139 | 344,031 | 213,442 | |||||||||
| Percent of total revenue | 22.8 | % | 41.9 | % | 29.3 | % | ||||||
| Cash flows from investing activities: | ||||||||||||
| Purchases of short-term available-for-sale investments | (1,403,600 | ) | (1,661,176 | ) | (1,028,781 | ) | ||||||
| Maturities of short-term available-for-sale investments | 1,083,474 | 1,154,412 | 1,815,862 | |||||||||
| Sales of short-term available-for-sale investments | 215,998 | 291,900 | 1,298,044 | |||||||||
| Additions to property, plant and equipment | (35,164 | ) | (49,229 | ) | (42,315 | ) | ||||||
| Payments for acquisitions, net of cash acquired | (6,947 | ) | - | (1,943,704 | ) | |||||||
| Change in other assets | (1,180 | ) | (4,468 | ) | (340 | ) | ||||||
| Net cash (used for) provided by investing activities | (147,419 | ) | (268,561 | ) | 98,766 | |||||||
| Cash flows from financing activities: | ||||||||||||
| Proceeds from debt | - | - | 1,995,398 | |||||||||
| Dividend payments to shareholders | (125,511 | ) | (124,882 | ) | (116,098 | ) | ||||||
| Repurchase of common stock | (31,340 | ) | (24,275 | ) | (57,394 | ) | ||||||
| Proceeds from employee stock plans | 19,988 | 52,090 | 36,045 | |||||||||
| Excess tax benefit - stock options | 6,373 | 11,142 | 9,322 | |||||||||
| Contingent consideration payment | (1,767 | ) | - | (1,803 | ) | |||||||
| Change in other financing activities | 4,327 | (3,563 | ) | 5,406 | ||||||||
| Net cash (used for) provided by financing activities | (127,930 | ) | (89,488 | ) | 1,870,876 | |||||||
| Effect of exchange rate changes on cash | (509 | ) | 32 | (433 | ) | |||||||
| Net (decrease) increase in cash and cash equivalents | (78,719 | ) | (13,986 | ) | 2,182,651 | |||||||
| Cash and cash equivalents at beginning of period | 636,216 | 650,202 | 402,790 | |||||||||
| Cash and cash equivalents at end of period | $ | 557,497 | $ | 636,216 | $ | 2,585,441 | ||||||
